Search

Search Constraints

You searched for: Author/Creator Hanusch, Claus

Search Results

1. 382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study. (4th December 2020)

2. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Issue 8 (August 2021)

3. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

4. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

5. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

6. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

7. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

8. Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. Issue 12 (6th July 2015)

9. Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. (March 2021)

10. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial. (January 2019)